McKesson Corporation vs YieldMax Magnificent 7 Fund of Option Income ETFs — how do they compare? McKesson Corporation trades at $899.7 (market cap $105.14B), while YieldMax Magnificent 7 Fund of Option Income ETFs trades at $11.38. The key difference: McKesson Corporation pays a 0.42% dividend while YieldMax Magnificent 7 Fund of Option Income ETFs pays none, and McKesson Corporation is trading nearer its 52-week high, YieldMax Magnificent 7 Fund of Option Income ETFs nearer its low. Which is the better fit depends on your goals.
| MCK | YMAG | |
|---|---|---|
Market Cap | $105.14B | — |
Sector | Health | Income / Options Overlay |
52-Week High | $995.69 | $15.98 |
52-Week Low | $659.01 | $10.76 |
Enterprise Value | $111.67B | — |
Dividend Yield | 0.42% | — |
Trailing returns across standard periods
McKesson is a leading wholesaler of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and Cardinal Health, the three account for well over 90% of the U.S. pharmaceutical wholesale industry. McKesson is currently divesting from its pharmaceutical wholesale and distribution in Europe and Canada in order to redeploy capital to strategic growth areas in the U.S. (oncology network and ecosystem, and biopharma services). Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
Read more on MCK →YMAG is an actively managed 'fund of funds' that provides equal-weighted exposure to the seven YieldMax ETFs tracking the 'Magnificent 7' tech giants (Apple, Microsoft, Alphabet, Amazon, Nvidia, Meta, and Tesla). It seeks to generate high current income by harvesting option premiums across these leaders, offering a streamlined way to access concentrated tech volatility in an income-producing format.
Read more on YMAG →